Aclarion Inc Net Assets
Aclarion Inc net assets. Based on the latest financial reports, Aclarion Inc (ACON) has net assets worth $12.50 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($13.20 Million) and total liabilities ($699.75K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore ACON net assets growth trend to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $12.50 Million |
| % of Total Assets | 94.7% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Net Assets of Aclarion Inc (2019–2024)
Net assets of Aclarion Inc from 2019 to 2024. This chart illustrates how Aclarion Inc's net assets have evolved over time, based on quarterly financial data. See Aclarion Inc (ACON) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Aclarion Inc (2019–2024)
The table below shows the annual net assets of Aclarion Inc from 2019 to 2024. For live market cap and overall valuation, see market value of Aclarion Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $970.06K | +233.25% |
| 2023-12-31 | $-728.00K | -132.70% |
| 2022-12-31 | $2.23 Million | +138.85% |
| 2021-12-31 | $-5.73 Million | +19.12% |
| 2020-12-31 | $-7.08 Million | -316.21% |
| 2019-12-31 | $-1.70 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Aclarion Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3081908300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Aclarion Inc Net Assets Breakdown (December 2024)
Aclarion Inc net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $52.23 Million | 5384.46% |
| Total Equity | $970.06K | 100.00% |
Aclarion Inc Competitors by Market Cap
The table below lists competitors of Aclarion Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Starbox Group Holdings Ltd. Ordinary Shares
NASDAQ:STBX
|
$1.14 Million |
|
Clean Motion AB
ST:CLEMO
|
$1.14 Million |
|
Borders & Southern Petroleum plc
LSE:BOR
|
$1.14 Million |
|
DCM Financial Services Limited
NSE:DCMFINSERV
|
$1.14 Million |
|
BEACN Wizardry & Magic Inc
V:BECN
|
$1.13 Million |
|
2cureX AB
ST:2CUREX
|
$1.13 Million |
|
Superior Mining International Corp
V:SUI
|
$1.13 Million |
|
Ambipar Emergency Response
NYSE:AMBIQ
|
$1.13 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aclarion Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -727,995 to 970,057, a change of 1,698,052.
- Net loss of 6,992,927 reduced equity.
- Dividend payments of 59,675 reduced retained earnings.
- New share issuances of 6,573,075 increased equity.
- Other factors increased equity by 2,177,579.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-6.99 Million | -720.88% |
| Dividends Paid | $59.67K | -6.15% |
| Share Issuances | $6.57 Million | +677.6% |
| Other Changes | $2.18 Million | +224.48% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Aclarion Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $-34299.40 | $1.95 | x |
| 2020-12-31 | $-142756.99 | $1.95 | x |
| 2021-12-31 | $-115463.91 | $1.95 | x |
| 2022-12-31 | $52760.32 | $1.95 | x |
| 2023-12-31 | $-11825.78 | $1.95 | x |
| 2024-12-31 | $1028.87 | $1.95 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aclarion Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -720.88%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -15293.78%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 2.19x
- Recent ROE (-720.88%) is below the historical average (-173.07%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | -14943.15% | 0.02x | 0.00x | $-3.85 Million |
| 2020 | 0.00% | -9527.35% | 0.04x | 0.00x | $-3.93 Million |
| 2021 | 0.00% | -8210.53% | 0.03x | 0.00x | $-4.38 Million |
| 2022 | -317.55% | -11694.45% | 0.02x | 1.31x | $-7.29 Million |
| 2023 | 0.00% | -6513.41% | 0.03x | 0.00x | $-4.84 Million |
| 2024 | -720.88% | -15293.78% | 0.02x | 2.19x | $-7.09 Million |
Industry Comparison
This section compares Aclarion Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $643,946,368
- Average return on equity (ROE) among peers: 4.94%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aclarion Inc (ACON) | $12.50 Million | 0.00% | 0.06x | $1.14 Million |
| American Well Corp (AMWL) | $1.25 Billion | -18.01% | 0.10x | $133.17 Million |
| Heartbeam Inc (BEAT) | $63.68 Million | -15.38% | 0.96x | $25.09 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $-1.01 Million | 0.00% | 0.00x | $5.56 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $1.65 Billion | -1.09% | 2.59x | $10.63 Billion |
| Carlsmed, Inc. (CARL) | $-46.13 Million | 0.00% | 0.00x | $408.18 Million |
| CareCloud, Inc. (CCLD) | $38.87 Million | -5.50% | 0.23x | $74.79 Million |
| Certara Inc (CERT) | $1.05 Billion | -5.29% | 0.49x | $1.12 Billion |
| CareMax Inc (CMAX) | $4.95 Million | 121.69% | 3.92x | $381.50 |
| Claritev Corporation (CTEV) | $1.79 Billion | -32.00% | 3.12x | $409.15 Million |
About Aclarion Inc
Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom softwa… Read more